nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.149	0.201	CbGbCtD
Podofilox—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.141	0.189	CbGbCtD
Podofilox—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0968	0.13	CbGbCtD
Podofilox—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0968	0.13	CbGbCtD
Podofilox—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0618	0.0831	CbGbCtD
Podofilox—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0417	0.0561	CbGbCtD
Podofilox—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0407	0.0547	CbGbCtD
Podofilox—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0398	0.0535	CbGbCtD
Podofilox—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0355	0.0477	CbGbCtD
Podofilox—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0208	0.028	CbGbCtD
Podofilox—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0197	0.0264	CbGbCtD
Podofilox—Application site irritation—Tiotropium—chronic obstructive pulmonary disease	0.0101	0.0773	CcSEcCtD
Podofilox—Excoriation—Formoterol—chronic obstructive pulmonary disease	0.00751	0.0573	CcSEcCtD
Podofilox—Excoriation—Arformoterol—chronic obstructive pulmonary disease	0.00751	0.0573	CcSEcCtD
Podofilox—Etoposide—GSTT1—chronic obstructive pulmonary disease	0.00463	0.459	CrCbGaD
Podofilox—TUBA4A—respiratory system—chronic obstructive pulmonary disease	0.00432	0.105	CbGeAlD
Podofilox—TUBA4A—connective tissue—chronic obstructive pulmonary disease	0.00381	0.0924	CbGeAlD
Podofilox—Etoposide—GSTP1—chronic obstructive pulmonary disease	0.00366	0.363	CrCbGaD
Podofilox—Skin ulcer—Tiotropium—chronic obstructive pulmonary disease	0.00361	0.0276	CcSEcCtD
Podofilox—TUBA4A—bronchus—chronic obstructive pulmonary disease	0.00356	0.0864	CbGeAlD
Podofilox—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.807	CbGdCrCtD
Podofilox—TUBA4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00348	0.0845	CbGeAlD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00347	0.0496	CbGpPWpGaD
Podofilox—TUBA4A—trachea—chronic obstructive pulmonary disease	0.0032	0.0776	CbGeAlD
Podofilox—TUBB—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00295	0.0422	CbGpPWpGaD
Podofilox—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00284	0.0217	CcSEcCtD
Podofilox—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00269	0.0385	CbGpPWpGaD
Podofilox—TOP2A—bronchus—chronic obstructive pulmonary disease	0.00263	0.0639	CbGeAlD
Podofilox—TUBB—bronchus—chronic obstructive pulmonary disease	0.00261	0.0633	CbGeAlD
Podofilox—TUBB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00255	0.062	CbGeAlD
Podofilox—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00251	0.0192	CcSEcCtD
Podofilox—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00251	0.0192	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00238	0.034	CbGpPWpGaD
Podofilox—TUBB—trachea—chronic obstructive pulmonary disease	0.00234	0.0569	CbGeAlD
Podofilox—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.0178	CcSEcCtD
Podofilox—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.00234	0.0178	CcSEcCtD
Podofilox—TUBA4A—lung—chronic obstructive pulmonary disease	0.0023	0.0557	CbGeAlD
Podofilox—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.0169	CcSEcCtD
Podofilox—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00203	0.0155	CcSEcCtD
Podofilox—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00195	0.0278	CbGpPWpGaD
Podofilox—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.0143	CcSEcCtD
Podofilox—Etoposide—CYP1A2—chronic obstructive pulmonary disease	0.00178	0.177	CrCbGaD
Podofilox—Blister—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.013	CcSEcCtD
Podofilox—TOP2A—lung—chronic obstructive pulmonary disease	0.0017	0.0412	CbGeAlD
Podofilox—TUBB—lung—chronic obstructive pulmonary disease	0.00168	0.0409	CbGeAlD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.0126	CcSEcCtD
Podofilox—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.0121	CcSEcCtD
Podofilox—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.0118	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00152	0.0217	CbGpPWpGaD
Podofilox—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.0116	CcSEcCtD
Podofilox—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.0115	CcSEcCtD
Podofilox—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00151	0.0115	CcSEcCtD
Podofilox—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00148	0.0211	CbGpPWpGaD
Podofilox—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.00147	0.0356	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00145	0.0207	CbGpPWpGaD
Podofilox—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.011	CcSEcCtD
Podofilox—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00134	0.0192	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00132	0.0188	CbGpPWpGaD
Podofilox—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.00129	0.0314	CbGeAlD
Podofilox—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00973	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00125	0.0179	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00121	0.0173	CbGpPWpGaD
Podofilox—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00923	CcSEcCtD
Podofilox—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00923	CcSEcCtD
Podofilox—NR3C1—bronchus—chronic obstructive pulmonary disease	0.00121	0.0293	CbGeAlD
Podofilox—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00118	0.0287	CbGeAlD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00117	0.0168	CbGpPWpGaD
Podofilox—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00872	CcSEcCtD
Podofilox—NR3C1—trachea—chronic obstructive pulmonary disease	0.00109	0.0263	CbGeAlD
Podofilox—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00825	CcSEcCtD
Podofilox—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00821	CcSEcCtD
Podofilox—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.0154	CbGpPWpGaD
Podofilox—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00805	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00793	CcSEcCtD
Podofilox—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00785	CcSEcCtD
Podofilox—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00785	CcSEcCtD
Podofilox—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00774	CcSEcCtD
Podofilox—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00769	CcSEcCtD
Podofilox—Rash—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00767	CcSEcCtD
Podofilox—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00767	CcSEcCtD
Podofilox—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00765	CcSEcCtD
Podofilox—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000998	0.00762	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000989	0.0141	CbGpPWpGaD
Podofilox—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000977	0.014	CbGpPWpGaD
Podofilox—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000973	0.00743	CcSEcCtD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000973	0.0139	CbGpPWpGaD
Podofilox—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00742	CcSEcCtD
Podofilox—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000961	0.00734	CcSEcCtD
Podofilox—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000943	0.0072	CcSEcCtD
Podofilox—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000932	0.00712	CcSEcCtD
Podofilox—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000906	0.00692	CcSEcCtD
Podofilox—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0009	0.00687	CcSEcCtD
Podofilox—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000852	0.0065	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000838	0.0064	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000838	0.0064	CcSEcCtD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000827	0.0118	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000821	0.00627	CcSEcCtD
Podofilox—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000817	0.00624	CcSEcCtD
Podofilox—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000809	0.00618	CcSEcCtD
Podofilox—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000809	0.00618	CcSEcCtD
Podofilox—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000792	0.00605	CcSEcCtD
Podofilox—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000785	0.006	CcSEcCtD
Podofilox—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000785	0.006	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000783	0.0112	CbGpPWpGaD
Podofilox—NR3C1—lung—chronic obstructive pulmonary disease	0.00078	0.0189	CbGeAlD
Podofilox—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000769	0.00588	CcSEcCtD
Podofilox—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000764	0.00583	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000758	0.0108	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.000754	0.0108	CbGpPWpGaD
Podofilox—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000752	0.00574	CcSEcCtD
Podofilox—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000742	0.00567	CcSEcCtD
Podofilox—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000731	0.00559	CcSEcCtD
Podofilox—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000731	0.00559	CcSEcCtD
Podofilox—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000716	0.00547	CcSEcCtD
Podofilox—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000711	0.00543	CcSEcCtD
Podofilox—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00071	0.0102	CbGpPWpGaD
Podofilox—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000709	0.00542	CcSEcCtD
Podofilox—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00537	CcSEcCtD
Podofilox—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000691	0.00528	CcSEcCtD
Podofilox—Pain—Formoterol—chronic obstructive pulmonary disease	0.000691	0.00528	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000691	0.00989	CbGpPWpGaD
Podofilox—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00528	CcSEcCtD
Podofilox—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00524	CcSEcCtD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000683	0.00976	CbGpPWpGaD
Podofilox—Pain—Montelukast—chronic obstructive pulmonary disease	0.000677	0.00517	CcSEcCtD
Podofilox—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000676	0.00516	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000673	0.00963	CbGpPWpGaD
Podofilox—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00067	0.00512	CcSEcCtD
Podofilox—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000669	0.00511	CcSEcCtD
Podofilox—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000666	0.00508	CcSEcCtD
Podofilox—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00506	CcSEcCtD
Podofilox—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.00499	CcSEcCtD
Podofilox—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000637	0.00487	CcSEcCtD
Podofilox—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00483	CcSEcCtD
Podofilox—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000631	0.00482	CcSEcCtD
Podofilox—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.00479	CcSEcCtD
Podofilox—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00062	0.00473	CcSEcCtD
Podofilox—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00471	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000604	0.00864	CbGpPWpGaD
Podofilox—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000593	0.00453	CcSEcCtD
Podofilox—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000587	0.0084	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000584	0.00835	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000578	0.00826	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000576	0.00824	CbGpPWpGaD
Podofilox—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00437	CcSEcCtD
Podofilox—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00437	CcSEcCtD
Podofilox—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00056	0.00428	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.00055	0.00787	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000549	0.00785	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000544	0.00778	CbGpPWpGaD
Podofilox—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00413	CcSEcCtD
Podofilox—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.0041	CcSEcCtD
Podofilox—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00408	CcSEcCtD
Podofilox—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00408	CcSEcCtD
Podofilox—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.00754	CbGpPWpGaD
Podofilox—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000524	0.004	CcSEcCtD
Podofilox—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000516	0.00738	CbGpPWpGaD
Podofilox—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00393	CcSEcCtD
Podofilox—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00393	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000511	0.00731	CbGpPWpGaD
Podofilox—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00051	0.0073	CbGpPWpGaD
Podofilox—Rash—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00389	CcSEcCtD
Podofilox—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00389	CcSEcCtD
Podofilox—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000509	0.00389	CcSEcCtD
Podofilox—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000509	0.00389	CcSEcCtD
Podofilox—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00387	CcSEcCtD
Podofilox—Headache—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00387	CcSEcCtD
Podofilox—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00386	CcSEcCtD
Podofilox—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00385	CcSEcCtD
Podofilox—Rash—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00381	CcSEcCtD
Podofilox—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00381	CcSEcCtD
Podofilox—Headache—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00379	CcSEcCtD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000496	0.00709	CbGpPWpGaD
Podofilox—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00371	CcSEcCtD
Podofilox—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00368	CcSEcCtD
Podofilox—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00367	CcSEcCtD
Podofilox—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00365	CcSEcCtD
Podofilox—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.00664	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000462	0.00661	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—chronic obstructive pulmonary disease	0.000454	0.00649	CbGpPWpGaD
Podofilox—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00045	0.00344	CcSEcCtD
Podofilox—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00342	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000445	0.00636	CbGpPWpGaD
Podofilox—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.00335	CcSEcCtD
Podofilox—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000427	0.0061	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000426	0.00609	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000423	0.0975	CbGdCrCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000422	0.00603	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000413	0.0952	CbGdCrCtD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000411	0.00587	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000409	0.00585	CbGpPWpGaD
Podofilox—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000405	0.00309	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000397	0.00568	CbGpPWpGaD
Podofilox—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00303	CcSEcCtD
Podofilox—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.003	CcSEcCtD
Podofilox—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.00039	0.00558	CbGpPWpGaD
Podofilox—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00298	CcSEcCtD
Podofilox—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00548	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—chronic obstructive pulmonary disease	0.000381	0.00545	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000378	0.00541	CbGpPWpGaD
Podofilox—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000374	0.00286	CcSEcCtD
Podofilox—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.0053	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000367	0.00525	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000367	0.00525	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000365	0.00521	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000363	0.00519	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000356	0.00509	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.000349	0.00499	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000347	0.00497	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000347	0.00496	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00488	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000339	0.00485	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00483	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000337	0.00482	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000336	0.0048	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00252	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000323	0.00462	CbGpPWpGaD
Podofilox—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00243	CcSEcCtD
Podofilox—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00444	CbGpPWpGaD
Podofilox—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000309	0.00236	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000309	0.00441	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000305	0.00437	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000303	0.00433	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000301	0.00431	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000301	0.0043	CbGpPWpGaD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.00427	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.00422	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000293	0.00419	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00416	CbGpPWpGaD
Podofilox—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00221	CcSEcCtD
Podofilox—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000288	0.0022	CcSEcCtD
Podofilox—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00218	CcSEcCtD
Podofilox—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000284	0.00406	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000281	0.00402	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.00399	CbGpPWpGaD
Podofilox—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00211	CcSEcCtD
Podofilox—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00211	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000276	0.00394	CbGpPWpGaD
Podofilox—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.0021	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	0.000272	0.00389	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00027	0.00386	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000256	0.00366	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000256	0.00366	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00354	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000243	0.00348	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.00342	CbGpPWpGaD
Podofilox—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00172	CcSEcCtD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00314	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00306	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000213	0.00305	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00302	CbGpPWpGaD
Podofilox—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00161	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000209	0.003	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000208	0.00298	CbGpPWpGaD
Podofilox—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00155	CcSEcCtD
Podofilox—Rash—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00153	CcSEcCtD
Podofilox—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00153	CcSEcCtD
Podofilox—Headache—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00152	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000198	0.00284	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000195	0.00279	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000191	0.00274	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000191	0.00273	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000182	0.0026	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000181	0.00259	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000179	0.00257	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00253	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000176	0.00252	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.0025	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	0.000175	0.0025	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000174	0.00249	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00248	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000171	0.00244	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000169	0.00242	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000167	0.00239	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000164	0.00235	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000162	0.00231	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00228	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000157	0.00224	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000153	0.00218	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	0.000151	0.00216	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000151	0.00216	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000148	0.00211	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00205	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000143	0.00204	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000137	0.00196	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000132	0.00189	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000132	0.00189	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000132	0.00188	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00184	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00182	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00182	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000126	0.0018	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00179	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000122	0.00174	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000118	0.00168	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000114	0.00164	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000111	0.00159	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000108	0.00155	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000107	0.00154	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	0.000107	0.00153	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000106	0.00152	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000106	0.00151	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000101	0.00144	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.0001	0.00143	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	9.82e-05	0.0014	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.73e-05	0.00139	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.59e-05	0.00137	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.22e-05	0.00132	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.18e-05	0.00131	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.1e-05	0.0013	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.08e-05	0.0013	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.08e-05	0.0013	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	9.01e-05	0.00129	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.9e-05	0.00127	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	8.8e-05	0.00126	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	8.54e-05	0.00122	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.49e-05	0.00121	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.42e-05	0.0012	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.34e-05	0.00119	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	7.82e-05	0.00112	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.63e-05	0.00109	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.53e-05	0.00108	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	7.42e-05	0.00106	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.27e-05	0.00104	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.86e-05	0.000981	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.79e-05	0.000971	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—chronic obstructive pulmonary disease	6.48e-05	0.000926	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.37e-05	0.00091	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.28e-05	0.000898	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.87e-05	0.000839	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.85e-05	0.000837	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.77e-05	0.000825	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.55e-05	0.000793	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.51e-05	0.000788	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.5e-05	0.000787	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.47e-05	0.000782	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.29e-05	0.000757	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.21e-05	0.000745	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.13e-05	0.000734	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.91e-05	0.000703	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.87e-05	0.000697	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.78e-05	0.000684	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.46e-05	0.000638	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.44e-05	0.000636	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.85e-05	0.000551	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.54e-05	0.000506	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.96e-05	0.000423	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.88e-05	0.000411	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.67e-05	0.000382	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.61e-05	0.000374	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.58e-05	0.000369	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.51e-05	0.000359	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.41e-05	0.000344	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.36e-05	0.000337	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.17e-05	0.00031	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.000259	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.79e-05	0.000255	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.000238	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.58e-05	0.000226	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000225	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000222	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.42e-05	0.000203	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.000187	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000154	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000153	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000147	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1e-05	0.000143	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.48e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.45e-06	9.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.17e-06	8.82e-05	CbGpPWpGaD
